Posted by Michael Wonder on 27 Oct 2023
Legislation expands access to breakthrough Alzheimer’s treatment
26 October 2023 - There’s new hope in the fight against Alzheimer’s. Federal legislation called the Access to Innovative Treatments Act can turn this hope into reality for seniors afflicted by this disease.
In July, the FDA gave traditional approval to Leqembi (lecanemab), a new medicine that may reduce cognitive decline among Alzheimer’s patients by 27%. This treatment is part of a new drug class of monoclonal antibodies that reduces amyloid plaque buildups in the brain, the protein that accumulates in the brains of people with Alzheimer’s disease. These therapies offer patients and caregivers more quality time with loved ones.
